Recent Posts
- Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL
- Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th
- Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
- Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
- Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
Recent Comments
No comments to show.